Financial Contrast: Cantel Medical (CMD) & Its Peers

Cantel Medical (NYSE: CMD) is one of 104 public companies in the “Surgical & medical instruments” industry, but how does it compare to its rivals? We will compare Cantel Medical to similar businesses based on the strength of its earnings, dividends, profitability, valuation, analyst recommendations, risk and institutional ownership.

Insider & Institutional Ownership

How to Become a New Pot Stock Millionaire

85.0% of Cantel Medical shares are owned by institutional investors. Comparatively, 48.3% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 12.3% of Cantel Medical shares are owned by insiders. Comparatively, 16.7% of shares of all “Surgical & medical instruments” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent recommendations for Cantel Medical and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cantel Medical 0 2 1 0 2.33
Cantel Medical Competitors 494 1871 3733 112 2.56

Cantel Medical presently has a consensus price target of $92.00, suggesting a potential downside of 15.44%. As a group, “Surgical & medical instruments” companies have a potential upside of 15.72%. Given Cantel Medical’s rivals stronger consensus rating and higher possible upside, analysts clearly believe Cantel Medical has less favorable growth aspects than its rivals.

Dividends

Cantel Medical pays an annual dividend of $0.17 per share and has a dividend yield of 0.2%. Cantel Medical pays out 8.2% of its earnings in the form of a dividend. As a group, “Surgical & medical instruments” companies pay a dividend yield of 1.2% and pay out 32.7% of their earnings in the form of a dividend.

Earnings & Valuation

This table compares Cantel Medical and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Cantel Medical $770.16 million $71.37 million 52.31
Cantel Medical Competitors $1.54 billion $111.91 million -141.70

Cantel Medical’s rivals have higher revenue and earnings than Cantel Medical. Cantel Medical is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Cantel Medical and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cantel Medical 10.92% 17.18% 11.19%
Cantel Medical Competitors -61.96% -46.96% -18.08%

Risk and Volatility

Cantel Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Cantel Medical’s rivals have a beta of 0.80, indicating that their average stock price is 20% less volatile than the S&P 500.

Summary

Cantel Medical rivals beat Cantel Medical on 8 of the 15 factors compared.

About Cantel Medical

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The Company’s Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The Company’s Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The Company offers a range of filters utilizing hollow fiber membrane technology.

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply